The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes
暂无分享,去创建一个
A. Roses | M. Sano | A. Saunders | J. Silverman | Irit Lubitz | M. Lutz | E. Kravitz | M. Beeri | A. Heymann | L. Greenbaum | I. Cooper | Ramit Ravona Springer
[1] Michael W. Lutz,et al. The cis-regulatory effect of an Alzheimer’s disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes , 2014, Alzheimer's & Dementia.
[2] Lorna M. Lopez,et al. A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing , 2014, Molecular Psychiatry.
[3] M. Sano,et al. Haptoglobin 1-1 Genotype Is Associated With Poorer Cognitive Functioning in the Elderly With Type 2 Diabetes , 2013, Diabetes Care.
[4] P. Crane,et al. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ɛ3/ɛ3 , 2013, Alzheimer's & Dementia.
[5] J. Ávila,et al. Deconstructing Mitochondrial Dysfunction in Alzheimer Disease , 2013, Oxidative medicine and cellular longevity.
[6] A. Roses,et al. TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial , 2013, Alzheimer's & Dementia.
[7] A. Roses,et al. Using Genetics to Enable Studies on the Prevention of Alzheimer's Disease , 2013, Clinical pharmacology and therapeutics.
[8] A. Roses,et al. Longitudinal modeling of cognitive aging and the TOMM40 effect , 2012, Alzheimer's & Dementia.
[9] Paul K Crane,et al. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. , 2012, Archives of neurology.
[10] A. Roses,et al. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging , 2012, Alzheimer's & Dementia.
[11] B. Frier,et al. Diabetes and cognitive dysfunction , 2012, The Lancet.
[12] Beata Ferencz,et al. Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity , 2012, International journal of Alzheimer's disease.
[13] A. Roses,et al. Characterization of the Poly-T Variant in the TOMM40 Gene in Diverse Populations , 2012, PloS one.
[14] J. Luchsinger. Type 2 diabetes and cognitive impairment: linking mechanisms. , 2012, Journal of Alzheimer's disease : JAD.
[15] David M Holtzman,et al. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. , 2011, Archives of neurology.
[16] Robert C. Green,et al. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ɛ3/ɛ3 genotype , 2011, Alzheimer's & Dementia.
[17] S. Potkin,et al. Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort , 2010, Neurology.
[18] Michael Weiner,et al. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort , 2010, NeuroImage.
[19] A. Roses,et al. Genetic variation at a single locus and age of onset for Alzheimer's disease , 2010, Alzheimer's & Dementia.
[20] A D Roses,et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.
[21] Andrew J. Saykin,et al. Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.
[22] V. Haroutunian,et al. The effects of cardiovascular risk factors on cognitive compromise , 2009, Dialogues in clinical neuroscience.
[23] I. Deary,et al. Cognition and diabetes: a lifespan perspective , 2008, The Lancet Neurology.
[24] Richard Mayeux,et al. Relation of diabetes to mild cognitive impairment. , 2007, Archives of neurology.
[25] K. Markides,et al. Cognitive decline in older Mexican Americans with diabetes. , 2006, Journal of the National Medical Association.
[26] M. Sano,et al. Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old , 2006, Neurology.
[27] P. Scheltens,et al. Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.
[28] D. Stojanovski,et al. Dissection of the Mitochondrial Import and Assembly Pathway for Human Tom40* , 2005, Journal of Biological Chemistry.
[29] D. Bennett,et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. , 2004, Archives of neurology.
[30] S. Kish,et al. Mitochondria in Alzheimer's disease. , 2002, International review of neurobiology.
[31] R. Mayeux,et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.
[32] A. Folsom,et al. Cardiovascular risk factors and cognitive decline in middle-aged adults , 2001, Neurology.
[33] K Yaffe,et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. , 2000, Archives of internal medicine.
[34] S. Fernaeus,et al. Word production: dissociation of two retrieval modes of semantic memory across time. , 1998, Journal of clinical and experimental neuropsychology.
[35] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[36] N. Cauthen. Verbal fluency: normative data. , 1978, Journal of clinical psychology.
[37] R. Reitan. The relation of the trail making test to organic brain damage. , 1955, Journal of consulting psychology.